SNT 5.00% 4.2¢ syntara limited

Ann: EU Marketing Authorisation Application Revie, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 817 Posts.
    lightbulb Created with Sketch. 191
    re: Ann: EU Marketing Authorisation Applicati... I agree TGA approval does not guarantee other approvals.
    We have seen that with Bronchitol.

    Movectro was rejected due to safety concerns. There was an increase in patients with cancer after being on the drug. It may or may not be linked but the EMEA won't take the risk and rightly so on this one.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
0.002(5.00%)
Mkt cap ! $57.67M
Open High Low Value Volume
4.0¢ 4.3¢ 4.0¢ $48.01K 1.160M

Buyers (Bids)

No. Vol. Price($)
3 1025000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 461843 2
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.